Results 21 to 30 of about 61,893 (290)
Investigating Nontuberculous Mycobacteria Transmission at the Colorado Adult Cystic Fibrosis Program
American Journal of Respiratory and Critical Care Medicine, 2022 Rationale Healthcare-associated transmission of nontuberculous mycobacteria (NTM) among people with cystic fibrosis (pwCF) has been investigated at CF centers worldwide, with conflicting conclusions.
J. E. Gross +14 more
semanticscholar +1 more source
Evaluation of MALDI Biotyper Mycobacteria Library for Identification of Nontuberculous Mycobacteria
Journal of Clinical Microbiology, 2022 The Bruker Biotyper matrix-assisted laser desorption ionization–time-of-flight mass spectrometry (MALDI-TOF MS) platform was assessed on its ability to accurately identify 314 nontuberculous mycobacteria (NTM) representing 73 species.
N. Toney +7 more
semanticscholar +1 more source
Emerging Infectious Diseases, 2021 Nontuberculous mycobacteria (NTM) cause pulmonary and extrapulmonary infections in susceptible persons. To characterize the epidemiology of skin and soft tissue (SST) and disseminated extrapulmonary infections caused by NTM in the United States, we used ...
E. Ricotta +5 more
semanticscholar +1 more source
Nontuberculous Mycobacteria, Macrophages, and Host Innate Immune Response
Infection and Immunity, 2021 Although nontuberculous mycobacteria (NTM) are considered opportunistic infections, incidence and prevalence of NTM infection are increasing worldwide becoming a major public health threat. Innate immunity plays an essential role in mediating the initial
M. Shamaei, M. Mirsaeidi
semanticscholar +1 more source
Journal of Pure and Applied Microbiology, 2022 Nontuberculous mycobacteria (NTM) are free-living organisms ubiquitously present in the environment. In recent times, NTM gained much importance due to the increase in incidence globally.
T. Kalpana +3 more
doaj +1 more source
Nontuberculous mycobacteria infection and pulmonary disease in bronchiectasis
ERJ Open Research, 2022 Background Although interest in nontuberculous mycobacteria (NTM) infection has increased in the last decades, published data vary according to different geographical areas, diagnostic facilities and quality of study design.
K. Suska +10 more
semanticscholar +1 more source
Nontuberculous Mycobacteria: Ecology and Impact on Animal and Human Health
Microorganisms, 2022 Nontuberculous mycobacteria (NTM) represent an important group of environmentally saprophytic and potentially pathogenic bacteria that can cause serious mycobacterioses in humans and animals.
I. Pavlik, V. Ulmann, J. Falkinham
semanticscholar +1 more source
Phage Therapy for Nontuberculous Mycobacteria: Challenges and Opportunities
Pulmonary Therapy, 2022 Non-tuberculous mycobacterium (NTM) infections are often clinically challenging, with lengthy antibiotic regimens that fail to resolve the infections with few good outcomes remaining.
G. Hatfull
semanticscholar +1 more source
The Heterogeneous World of Nontuberculous Mycobacteria in Bronchiectasis. [PDF]
Am J Respir Crit Care MedMartinez-Garcia MA.
europepmc +2 more sources
In Vitro Susceptibility Testing of Eravacycline against Nontuberculous Mycobacteria
Antimicrobial Agents and Chemotherapy, 2022 Nontuberculous mycobacteria (NTM) infections are increasing worldwide. Mycobacterium avium complex (MAC) and the M. abscessus species are the most commonly cultured NTM and treatment options are limited, especially for the M. abscessus species.
B. Brown-Elliott, R. Wallace
semanticscholar +1 more source